Baxter International (BAX) Research & Development (2016 - 2024)
Historic Research & Development for Baxter International (BAX) over the last 16 years, with Q1 2024 value amounting to $176.0 million.
- Baxter International's Research & Development rose 731.71% to $176.0 million in Q1 2024 from the same period last year, while for Mar 2024 it was $530.0 million, marking a year-over-year increase of 1397.85%. This contributed to the annual value of $518.0 million for FY2025, which is 1220.34% down from last year.
- As of Q1 2024, Baxter International's Research & Development stood at $176.0 million, which was up 731.71% from $23.0 million recorded in Q4 2023.
- Baxter International's 5-year Research & Development high stood at $176.0 million for Q1 2024, and its period low was $2.0 million during Q4 2022.
- For the 5-year period, Baxter International's Research & Development averaged around $129.2 million, with its median value being $139.0 million (2021).
- Its Research & Development has fluctuated over the past 5 years, first crashed by 9851.85% in 2022, then surged by 105000.0% in 2023.
- Quarter analysis of 5 years shows Baxter International's Research & Development stood at $135.0 million in 2020, then changed by 0.0% to $135.0 million in 2021, then tumbled by 98.52% to $2.0 million in 2022, then skyrocketed by 1050.0% to $23.0 million in 2023, then skyrocketed by 665.22% to $176.0 million in 2024.
- Its Research & Development was $176.0 million in Q1 2024, compared to $23.0 million in Q4 2023 and $166.0 million in Q3 2023.